
11 - 50 employees
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Avalyn Pharma is a biopharma company dedicated to developing innovative medicines aimed at treating rare lung diseases. The company is currently conducting the MIST Study, a Phase 2b clinical trial assessing the safety and efficacy of an inhaled version of pirfenidone, known as AP01, for patients diagnosed with Progressive Pulmonary Fibrosis (PPF). Through their research, Avalyn Pharma seeks to improve lung function and the overall quality of life for individuals suffering from this serious condition.
Selected: 🆕 Date Added.
🕒 August 21
Clinical development director leading IPF/ILD trials for Avalyn, which develops inhaled therapies for rare respiratory diseases. Overseeing medical strategy, safety, data interpretation, and regulatory activities.
🇺🇸 United States – Remote
💵 $220k - $240k / year
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 2%